Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

18.8%

3 terminated/withdrawn out of 16 trials

Success Rate

25.0%

-61.6% vs industry average

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

300%

3 of 1 completed trials have results

Key Signals

5 recruiting3 with results

Enrollment Performance

Analytics

N/A
8(50.0%)
Phase 2
6(37.5%)
Phase 3
1(6.3%)
Early Phase 1
1(6.3%)
16Total
N/A(8)
Phase 2(6)
Phase 3(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (16)

Showing 16 of 16 trials
NCT07671768Not ApplicableNot Yet Recruiting

Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT Trial

Role: collaborator

NCT04815694Not ApplicableRecruiting

THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy

Role: collaborator

NCT04984343Phase 2Terminated

Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer

Role: collaborator

NCT05108428Early Phase 1Active Not Recruiting

Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

Role: collaborator

NCT04422132Phase 2Active Not Recruiting

Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks

Role: collaborator

NCT07223307Phase 2Recruiting

REGULUS: MRI-guided Adaptive SABR for Liver Cancers

Role: collaborator

NCT07276438Not ApplicableRecruiting

Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial

Role: collaborator

NCT07293585Phase 3Recruiting

Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment

Role: collaborator

NCT05301283Phase 2Recruiting

Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue Sarcoma

Role: collaborator

NCT03541850Phase 2Active Not Recruiting

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Role: collaborator

NCT04939246Not ApplicableCompleted

Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction

Role: collaborator

NCT04162665Phase 2Terminated

Pre-operative Adaptive Short Court Radiation Therapy in Gastric Cancer

Role: collaborator

NCT04376502Not ApplicableTerminated

Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.

Role: collaborator

NCT05585554Not ApplicableNot Yet Recruiting

Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy

Role: lead

NCT03621644Not ApplicableActive Not Recruiting

Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer

Role: lead

NCT05265663Not ApplicableUnknown

Stereotactic Radiotherapy vs Best Supportive Care in Unfit Pancreatic Cancer Patients

Role: collaborator

All 16 trials loaded